Dr. Lal PathLabs Ltd (BOM:539524)
₹ 3032.8 -65.45 (-2.11%) Market Cap: 252.57 Bil Enterprise Value: 242.94 Bil PE Ratio: 63.01 PB Ratio: 12.63 GF Score: 99/100

Q3 2022 Dr. Lal PathLabs Ltd Earnings Call Transcript

Feb 10, 2022 / 11:00AM GMT
Release Date Price: ₹2930.55 (-1.02%)
Operator

Ladies and gentlemen, good day, and welcome to the Dr. Lal PathLabs Q3 FY '22 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Nishid Solanki of CDR India. Thank you. And over to you, sir.

Nishid Solanki
CDR India - IR Manager

Thank you. Good afternoon, everyone, and welcome to Dr. Lal PathLabs Q3 FY '22 Earnings Conference Call. Today, we are joined by senior members of the management team, including Honorary, Brigadier, Dr. Arvind Lal, Executive Chairman; Dr. Om Prakash Manchanda, Managing Director; Mr. Bharath, CEO; Mr. Ved Prakash Goel, Group CFO; along with Mr. Rajat Kalra, Company Secretary and Head of Investor Relations.

I would leave you with a standard disclaimer here. Some of the statements made on today's call could be forward-looking in nature, and the actual results could vary from these forward-looking statements. A detailed statement in this regard is available in the results presentation, which has been circulated to you, and also available on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot